Indeed, it could be used for reversing conditions of hypercoagulability but also be employed in diagnostic assays to measure the levels of Factor V in human blood samples to highlight FV deficits in patients with hemorrhagic symptoms, and, finally, it could be used to purify Factor V for the development of therapeutic products. The gene discussed is F5; the disease is thrombophilia.